1552 related articles for article (PubMed ID: 30326284)
1. Formulation performance and processability window for manufacturing a dual-polymer amorphous solid dispersion via hot-melt extrusion and strand pelletization.
Hörmann TR; Jäger N; Funke A; Mürb RK; Khinast JG; Paudel A
Int J Pharm; 2018 Dec; 553(1-2):408-421. PubMed ID: 30326284
[TBL] [Abstract][Full Text] [Related]
2. A New Extrudable Form of Hypromellose: AFFINISOL™ HPMC HME.
Huang S; O'Donnell KP; Keen JM; Rickard MA; McGinity JW; Williams RO
AAPS PharmSciTech; 2016 Feb; 17(1):106-19. PubMed ID: 26335416
[TBL] [Abstract][Full Text] [Related]
3. Ternary Amorphous Solid Dispersions Containing a High-Viscosity Polymer and Mesoporous Silica Enhance Dissolution Performance†.
Hanada M; Jermain SV; Thompson SA; Furuta H; Fukuda M; Williams RO
Mol Pharm; 2021 Jan; 18(1):198-213. PubMed ID: 33291881
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity of a continuous hot-melt extrusion and strand pelletization line to control actions and composition variation.
Hörmann TR; Rehrl J; Scheibelhofer O; Schaden LM; Funke A; Makert C; Khinast JG
Int J Pharm; 2019 Jul; 566():239-253. PubMed ID: 31103818
[TBL] [Abstract][Full Text] [Related]
5. Investigation into Intermolecular Interactions and Phase Behavior of Binary and Ternary Amorphous Solid Dispersions of Ketoconazole.
Sarpal K; Tower CW; Munson EJ
Mol Pharm; 2020 Mar; 17(3):787-801. PubMed ID: 31860316
[TBL] [Abstract][Full Text] [Related]
6. Predicting physical stability of ternary amorphous solid dispersions using specific mechanical energy in a hot melt extrusion process.
Hanada M; Jermain SV; Lu X; Su Y; Williams RO
Int J Pharm; 2018 Sep; 548(1):571-585. PubMed ID: 30006310
[TBL] [Abstract][Full Text] [Related]
7. Part I: characterization of solid dispersions of nimodipine prepared by hot-melt extrusion.
Zheng X; Yang R; Tang X; Zheng L
Drug Dev Ind Pharm; 2007 Jul; 33(7):791-802. PubMed ID: 17654028
[TBL] [Abstract][Full Text] [Related]
8. Lacidipine Amorphous Solid Dispersion Based on Hot Melt Extrusion: Good Miscibility, Enhanced Dissolution, and Favorable Stability.
Xi L; Song H; Wang Y; Gao H; Fu Q
AAPS PharmSciTech; 2018 Oct; 19(7):3076-3084. PubMed ID: 30094722
[TBL] [Abstract][Full Text] [Related]
9. The design and development of high drug loading amorphous solid dispersion for hot-melt extrusion platform.
Tian Y; Jacobs E; Jones DS; McCoy CP; Wu H; Andrews GP
Int J Pharm; 2020 Aug; 586():119545. PubMed ID: 32553496
[TBL] [Abstract][Full Text] [Related]
10. Chemically identical but physically different: A comparison of spray drying, hot melt extrusion and cryo-milling for the formulation of high drug loaded amorphous solid dispersions of naproxen.
Dedroog S; Huygens C; Van den Mooter G
Eur J Pharm Biopharm; 2019 Feb; 135():1-12. PubMed ID: 30529295
[TBL] [Abstract][Full Text] [Related]
11. Hot melt extrusion versus spray drying: hot melt extrusion degrades albendazole.
Hengsawas Surasarang S; Keen JM; Huang S; Zhang F; McGinity JW; Williams RO
Drug Dev Ind Pharm; 2017 May; 43(5):797-811. PubMed ID: 27616147
[TBL] [Abstract][Full Text] [Related]
12. Reactive Melt Extrusion To Improve the Dissolution Performance and Physical Stability of Naproxen Amorphous Solid Dispersions.
Liu X; Zhou L; Zhang F
Mol Pharm; 2017 Mar; 14(3):658-673. PubMed ID: 28135108
[TBL] [Abstract][Full Text] [Related]
13. Amorphous-state characterization of efavirenz--polymer hot-melt extrusion systems for dissolution enhancement.
Sathigari SK; Radhakrishnan VK; Davis VA; Parsons DL; Babu RJ
J Pharm Sci; 2012 Sep; 101(9):3456-64. PubMed ID: 22437488
[TBL] [Abstract][Full Text] [Related]
14. Hot melt extrusion (HME) for amorphous solid dispersions: predictive tools for processing and impact of drug-polymer interactions on supersaturation.
Sarode AL; Sandhu H; Shah N; Malick W; Zia H
Eur J Pharm Sci; 2013 Feb; 48(3):371-84. PubMed ID: 23267847
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of the potential of poly(2-ethyl-2-oxazoline) as carrier in the formulation of amorphous solid dispersions of poorly soluble drugs.
Boel E; Smeets A; Vergaelen M; De la Rosa VR; Hoogenboom R; Van den Mooter G
Eur J Pharm Biopharm; 2019 Nov; 144():79-90. PubMed ID: 31499162
[TBL] [Abstract][Full Text] [Related]
16. Comparison of HPMC based polymers performance as carriers for manufacture of solid dispersions using the melt extruder.
Ghosh I; Snyder J; Vippagunta R; Alvine M; Vakil R; Tong WQ; Vippagunta S
Int J Pharm; 2011 Oct; 419(1-2):12-9. PubMed ID: 21782911
[TBL] [Abstract][Full Text] [Related]
17. Five-Stage Approach for a Systematic Screening and Development of Etravirine Amorphous Solid Dispersions by Hot-Melt Extrusion.
Simões MF; Pereira A; Cardoso S; Cadonau S; Werner K; Pinto RMA; Simões S
Mol Pharm; 2020 Feb; 17(2):554-568. PubMed ID: 31774685
[TBL] [Abstract][Full Text] [Related]
18. Optimising Drug Solubilisation in Amorphous Polymer Dispersions: Rational Selection of Hot-melt Extrusion Processing Parameters.
Li S; Tian Y; Jones DS; Andrews GP
AAPS PharmSciTech; 2016 Feb; 17(1):200-13. PubMed ID: 26729536
[TBL] [Abstract][Full Text] [Related]
19. Extended release delivery system of metoprolol succinate using hot-melt extrusion: effect of release modifier on methacrylic acid copolymer.
Sawant KP; Fule R; Maniruzzaman M; Amin PD
Drug Deliv Transl Res; 2018 Dec; 8(6):1679-1693. PubMed ID: 29948916
[TBL] [Abstract][Full Text] [Related]
20. Novel supercritical carbon dioxide impregnation technique for the production of amorphous solid drug dispersions: a comparison to hot melt extrusion.
Potter C; Tian Y; Walker G; McCoy C; Hornsby P; Donnelly C; Jones DS; Andrews GP
Mol Pharm; 2015 May; 12(5):1377-90. PubMed ID: 25730138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
